Regentis Biomaterials LTD.
SEC CIK 1912966 · RGNT · last insider filing 2026-03-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Alpert Susan PHD MD | Director | filed 2026 - 2026 |
| Geller Ehud | Director · Chief Executive Officer | filed 2026 - 2026 |
| Valentine Keith | Director | filed 2026 - 2026 |
| Dykan Jeff | Director | filed 2026 - 2026 |
| Cohen-Arazi Efraim | Director | filed 2026 - 2026 |
| Ben-Elazar Pini | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Reske Galit | Chief Medical Officer | filed 2026 - 2026 |
| Gon Ori | Chief Financial Officer | filed 2026 - 2026 |
| Gordashnikov Arie | Chief Accounting Officer | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.